Is antiviral treatment necessary for Epstein-Barr Virus (EBV) infections?

The correct answer indicates that antiviral treatment is not necessary for Epstein-Barr Virus (EBV) infections in the majority of cases. EBV is known to cause infectious mononucleosis and, in most instances, the infection is self-limiting. Patients typically recover with supportive care, which includes rest, hydration, and symptomatic relief rather than specific antiviral therapy.

Most individuals with a healthy immune system will manage the infection on their own, and only a small subset of patients may require additional medical intervention. This aligns with the general medical approach to viral infections, where antiviral medications are reserved primarily for situations where the benefits outweigh the risks, such as in severe cases or specific patient populations who may be at risk of complications.

In contrast, the other options suggest a need for antiviral treatments either universally or under circumstances that do not always apply. While severe cases or immunocompromised patients may indeed warrant closer monitoring and potential antiviral therapy, it is not a standard requirement for all patients with EBV, reinforcing why the selected answer is accurate.